Antihypertensive efficacy and tolerability of FAAC was investigated in open noncomparative study in 22 centers in 17 cities of Russia on 570 patients ( 246 men , 324 women ) aged 18-65 years ( mean 55,53 +8,55 years ) with 1-3 degree arterial hypertension .
